Application of Quality by Design Approach in the Optimization and Development of the UPLC Analytical Method for Determination of Fusidic Acid in Pharmaceutical Products

Application of Quality by Design Approach in the Optimization and Development of the UPLC Analytical Method for Determination of Fusidic Acid in Pharmaceutical Products

Background: Analytical techniques are a crucial method used in quality control procedures. Fusidic acid (FU), an antibacterial drug, is available on the market in a semisolid dosage form. This work aimed to develop a simple, sensitive, and robust UPLC assay for FU. Method: The effect of the formic a...

Full description

Bibliographic Details
Main Authors:	Mohamed Ibrahim, Nasser Ali Alhabib, Doaa Alshora, Mounir M. Salem Bekhit, Ehab Taha, Wael A. Mahdi, Abdulelah M. Harthi
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Separations
Subjects:	fusidic acid UPLC optimization response surface methodology
Online Access:	https://www.mdpi.com/2297-8739/10/5/318

Similar Items

Structures of the Staphylococcus aureus ribosome inhibited by fusidic acid and fusidic acid cyclopentane
by: Adrián González-López, et al.
Published: (2024-06-01)

Efficacy of using antibacterial fusidic acid drops in patients with red eye
by: G.I.Drozhzhyna, et al.
Published: (2016-12-01)

Development and characterization of niosomal gel of fusidic acid: in-vitro and ex-vivo approaches
by: Muhammad Khurram Waqas, et al.
Published: (2022-12-01)

The Dissemination of Fusidic Acid Resistance Among Staphylococcus epidermidis Clinical Isolates in Wenzhou, China
by: Chen S, et al.
Published: (2022-05-01)

Exploration of the Fusidic Acid Structure Activity Space for Antibiotic Activity
by: Yoon-Suk Kang, et al.
Published: (2025-01-01)

Growth inhibition by fusidic acid in cervical, thyroid, and breast carcinoma cell lines
by: Jin Young Kim, et al.
Published: (2023-03-01)

Cost-Minimization of Availability of Fusidic Acid in the Treatment of Topical Infection in Iran
by: Meysam Seyedifar, et al.
Published: (2018-05-01)

Effect of Fusidic Acid and Some Nitrogen-Containing Derivatives on Liposomal and Mitochondrial Membranes
by: Mikhail V. Dubinin, et al.
Published: (2023-10-01)

Stability-indicating RP-LC method for quantification of fusidic acid in cream
by: Mariane Machado Curbete, et al.

Novel Formulation of Fusidic Acid Incorporated into a Myrrh-Oil-Based Nanoemulgel for the Enhancement of Skin Bacterial Infection Treatment
by: Mervt M. Almostafa, et al.
Published: (2022-04-01)

Fusidic Acid and Lidocaine-Loaded Electrospun Nanofibers as a Dressing for Accelerated Healing of Infected Wounds
by: Alsulami KA, et al.
Published: (2025-01-01)

Novel Fusidic Acid Cream Containing Metal Ions and Natural Products against Multidrug-Resistant Bacteria
by: Hani Naseef, et al.
Published: (2022-08-01)

Ligand and structure-based approaches for the exploration of structure–activity relationships of fusidic acid derivatives as antibacterial agents
by: Wende Zheng, et al.
Published: (2023-01-01)

Fast on-site simultaneous electroanalysis of fusidic acid and betamethasone in pharmaceuticals and water samples using novel stochastic platform
by: Bianca-Maria Tuchiu, et al.
Published: (2023-12-01)

Synthesis and Biological Evaluation of Novel Fusidic Acid Derivatives as Two-in-One Agent with Potent Antibacterial and Anti-Inflammatory Activity
by: Borong Tu, et al.
Published: (2022-07-01)

Enhancing the Topical Antibacterial Activity of Fusidic Acid via Embedding into Cinnamon Oil Nano-Lipid Carrier
by: Heba S. Elsewedy, et al.
Published: (2024-04-01)

The anti-staphylococcal fusidic acid as an efflux pump inhibitor combined with fluconazole against vaginal candidiasis in mouse model
by: Salwa E. Gomaa, et al.
Published: (2024-02-01)

Polymyxin B and fusidic acid, a novel potent synergistic combination against Klebsiella pneumoniae and Escherichia coli isolates with polymyxin B resistance
by: Shuying Chen, et al.
Published: (2023-10-01)

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance
by: Wenjing Chen, et al.
Published: (2020-06-01)

3-Amino-Substituted Analogues of Fusidic Acid as Membrane-Active Antibacterial Compounds
by: Elena V. Salimova, et al.
Published: (2023-03-01)

Transcriptomic and Metabolomic Analysis of a Fusidic Acid-Selected <i>fusA</i> Mutant of <i>Staphylococcus aureus</i>
by: Sushim K. Gupta, et al.
Published: (2022-08-01)

A Robust and Reliable UPLC Method for the Simultaneous Quantification of Rosuvastatin Calcium, Glibenclamide, and Candesartan Cilexetil
by: Mohamed Abbas Ibrahim, et al.
Published: (2024-04-01)

A fusidic acid-resistant (PVL+) clone is associated with the increase in methicillin-resistant Staphylococcus aureus in New Caledonia
by: Alexandre Bourles, et al.
Published: (2022-09-01)

Optimization and Validation of Sensitive UPLC-PDA Method for Simultaneous Determination of Thymoquinone and Glibenclamide in SNEDDs Formulations Using Response Surface Methodology
by: Doaa Hasan Alshora, et al.
Published: (2023-11-01)

Nanocrystals of Fusidic Acid for Dual Enhancement of Dermal Delivery and Antibacterial Activity: In Vitro, Ex Vivo and In Vivo Evaluation
by: Iman S. Ahmed, et al.
Published: (2020-02-01)

Solriamfetol impurities: Synthesis, characterization, and analytical method (UPLC-UV) validation
by: Nafisah Al-Rifai, et al.
Published: (2023-04-01)

Current views on etiopathogenesis, clinical manifestations and treatment of pyodermas in children
by: O. B. Tamrazova, et al.
Published: (2020-03-01)

Development of a UPLC-MS/MS method for the determination of lacosamide and its metabolite and its application to drug-drug interaction
by: Jie Chen, et al.
Published: (2023-11-01)

Formulation of Glibenclamide proniosomes for oral administration: Pharmaceutical and pharmacodynamics evaluation
by: Doaa Alshora, et al.
Published: (2023-12-01)

Determination of mandipropamid residues in cucumber by UPLC-MS
by: ZHANG Zhouli, et al.
Published: (2023-12-01)

A Simple Stability-Indicating UPLC Method for the Concurrent Assessment of Paracetamol and Caffeine in Pharmaceutical Formulations
by: Wasim Ahmad, et al.
Published: (2023-01-01)

Rapid determination of erythrosine in beverages by UPLC
by: XIE Sai
Published: (2022-07-01)

Development of a UPLC-MS/MS method for the determination of orelabrutinib in rat plasma and its application in pharmacokinetics
by: Ya-nan Liu, et al.
Published: (2022-09-01)

UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma
by: Qingqing Li, et al.
Published: (2022-06-01)

A multifunctional injectable, self-healing, and adhesive hydrogel-based wound dressing stimulated diabetic wound healing with combined reactive oxygen species scavenging, hyperglycemia reducing, and bacteria-killing abilities
by: Rong Chen, et al.
Published: (2024-07-01)

Six-Year Retrospective Review of Hospital Data on Antimicrobial Resistance Profile of Staphylococcus aureus Isolated from Skin Infections from a Single Institution in Greece
by: Christina Stefanaki, et al.
Published: (2017-12-01)

Quality Evaluation of Tricholoma matsutake Based on the Nucleic Acid Compounds by UPLC-TOF/MS and UPLC-QqQ/MS
by: Ying Xue, et al.
Published: (2018-12-01)

Development and validation of UPLC-UV method for the determination of rubraxanthone in human plasma
by: Meri Susanti, et al.
Published: (2019-09-01)

Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach
by: Saha Chandni, et al.
Published: (2020-03-01)

Stability indicating RP-UPLC determination of three antiviral agents: emtricitabine, tenofovir, and rilpivirine in combined pharmaceutical dosage form
by: Vinutha Kommineni, et al.
Published: (2025-02-01)